Phase I/II study of carfilzomib, bendamustine, and dexamethasone (CBD) in patients with newly diagnosed multiple myeloma. uri icon

Overview

publication date

  • February 3, 2020

Research

keywords

  • Antineoplastic Combined Chemotherapy Protocols
  • Multiple Myeloma

Identity

PubMed Central ID

  • PMC6997347

Scopus Document Identifier

  • 85078902696

Digital Object Identifier (DOI)

  • 10.1038/s41408-020-0278-5

PubMed ID

  • 32015343

Additional Document Info

volume

  • 10

issue

  • 2